None of that is actionable.
1. Uplist
Nader has stated they are applying to the NYSE under exception 4a. They have to meet with the exchange and discuss why that applies to them. Getting on an exchange takes months.
Nothing actionable in saying the company has decided to try and uplist.
2. 50 million in financing.
Nader has stated they are seeking financing and shopping lenders. They have a few discussions on the table. If not there is the 100 million shares to ready to fund the company.
Nothing actionable about stating the company is seeking financing, that it is involved in discussions and it's intentions moving foward.
3. 2 billion in revenue in 2020.
During Nader's conference call he stated based on the number of vials they believe can be produced, the need of the market, that they projected 2 billion in potential revenue.
Nothing actionable in a CEO making statements that upon approval the company projects a potential revenue from it's new drug and the demand from the market. Otherwise the NYSE, NASDAQ and other exchanges would grind to a complete halt as projecting earnings suddenly becomes a crime.
4. Looks kind of haggard.
Fresh pressed suit, well tied Windsor knot, brilliant white shirt. Appears well groomed. No bags under the eyes, no discoloration from lack of sleep, no ruddy complexion from alcohol abuse. Shoulders are squared and good posture.
I would say using the word haggard is inappropriate and an incorrect analysis of his appearance.
MYTHS BUSTED
News 
Market Data 
Discover 
